Maxcyte (MXCT) Non-Current Assets (2020 - 2026)
Maxcyte (MXCT) posted quarterly Non-Current Assets of $71.5 million for Q1 2026, down 3.61% year-over-year from $74.2 million in Q1 2025, and down 14.98% quarter-over-quarter from $84.1 million in Q4 2025.
Maxcyte (MXCT) Non-Current Assets (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Non-Current Assets for 7 consecutive years, with $71.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 3.61% year-over-year to $71.5 million; the TTM figure through Mar 2026 stood at $321.0 million (up 9.36% YoY), while the FY2025 annual figure was $84.1 million, up 24.12% from the prior year.
- Non-Current Assets retreated to $71.5 million in Q1 2026 per MXCT's latest filing, from $84.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $88.8 million in Q3 2025 and bottomed at $25.2 million in Q1 2022.
- Historically, Non-Current Assets has averaged $60.0 million across 5 years, with a median of $71.5 million in 2026.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 318.61% — and 2024, when it declined 13.18%.
- Maxcyte's Non-Current Assets stood at $34.4 million in 2022, then soared by 127.06% to $78.1 million in 2023, then decreased by 13.18% to $67.8 million in 2024, then increased by 24.12% to $84.1 million in 2025, then slipped by 14.98% to $71.5 million in 2026.
- Business Quant data shows MXCT's Non-Current Assets at $71.5 million in Q1 2026, $84.1 million in Q4 2025, and $88.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Maxcyte | 148.48 Mn | 148.48 Mn | 5.60 Mn | 63.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.40 Mn |
| Mar 31, 2026 | 71.54 Mn |
| Dec 31, 2025 | 84.14 Mn |
| Sep 30, 2025 | 88.83 Mn |
| Jun 30, 2025 | 76.53 Mn |
| Mar 31, 2025 | 74.21 Mn |
| Dec 31, 2024 | 67.79 Mn |
| Sep 30, 2024 | 75.70 Mn |
| Jun 30, 2024 | 75.85 Mn |
| Mar 31, 2024 | 79.26 Mn |
| Dec 31, 2023 | 78.08 Mn |
| Sep 30, 2023 | 52.39 Mn |
| Jun 30, 2023 | 34.59 Mn |
| Mar 31, 2023 | 35.10 Mn |
| Dec 31, 2022 | 34.39 Mn |
| Sep 30, 2022 | 34.13 Mn |
| Jun 30, 2022 | 31.95 Mn |
| Mar 31, 2022 | 25.16 Mn |
| Dec 31, 2021 | 13.69 Mn |
| Sep 30, 2021 | 8.15 Mn |